Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $21,710 - $29,814
119 Added 3.33%
3,690 $726,000
Q2 2022

Aug 09, 2022

BUY
$204.13 - $302.4 $27,965 - $41,428
137 Added 3.99%
3,571 $764,000
Q1 2022

May 10, 2022

BUY
$255.51 - $362.11 $55,190 - $78,215
216 Added 6.71%
3,434 $975,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $2,108 - $2,692
-6 Reduced 0.19%
3,218 $953,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $30,929 - $38,038
-83 Reduced 2.51%
3,224 $1.31 Million
Q2 2021

Aug 10, 2021

SELL
$294.17 - $371.65 $11,178 - $14,122
-38 Reduced 1.14%
3,307 $1.2 Million
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $16,727 - $20,065
67 Added 2.04%
3,345 $980,000
Q4 2020

Feb 08, 2021

BUY
$222.0 - $252.62 $30,414 - $34,608
137 Added 4.36%
3,278 $819,000
Q3 2020

Nov 10, 2020

BUY
$175.56 - $226.45 $20,540 - $26,494
117 Added 3.87%
3,141 $711,000
Q2 2020

Aug 10, 2020

SELL
$118.84 - $189.72 $420,812 - $671,798
-3,541 Reduced 53.94%
3,024 $534,000
Q1 2020

Apr 23, 2020

BUY
$98.9 - $178.34 $22,153 - $39,948
224 Added 3.53%
6,565 $867,000
Q4 2019

Feb 12, 2020

BUY
$126.05 - $152.76 $799,283 - $968,651
6,341 New
6,341 $969,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Marks Group Wealth Management, Inc Portfolio

Follow Marks Group Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.